(Q46616032)

English

Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial

scientific article published on 21 July 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16040619

Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16040619

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic heart failure

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16040619

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16040619

Christian Torp-Pedersen

2

object named as

Christian Torp-Pedersen

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

6

object named as

Michel Komajda

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

3

object named as

Karl Swedberg

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

Andrea Di Lenarda

5

object named as

Andrea Di Lenarda

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16040619

Beatrix Lutiger

8

object named as

Beatrix Lutiger

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16040619

Willem J. Remme

7

object named as

Willem J Remme

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16040619

9

object named as

Armin Scherhag

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16040619

10

object named as

Mary Ann Lukas

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16040619

author name string

Andrew Charlesworth

11

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16040619

Philip A Poole-Wilson

12

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16040619

publication date

21 July 2005

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16040619

European Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16040619

26

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16040619

21

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16040619

2259-2268

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16040619

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

beta-adrenergic receptor blockade in chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Mode of death in heart failure: findings from the ATLAS trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Guidelines for the diagnosis and treatment of chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Predicting response to carvedilol for the treatment of heart failure: a multivariate retrospective analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Relation between heart rate, heart rhythm, and reverse left ventricular remodelling in response to carvedilol in patients with chronic heart failure: a single centre, observational study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Predictors of systolic and diastolic improvement in patients with dilated cardiomyopathy treated with metoprolol

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Beta-blocker efficacy according to heart rate and rhythm in patients with heart failure. Commentary on the Cardiac Insufficiency Bisoprolol Study II analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Do beta-blockers prolong survival in heart failure only by inhibiting the beta1-receptor? A perspective on the results of the COMET trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Beta blockers in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Selective versus nonselective beta-blockade for heart failure therapy: are there lessons to be learned from the COMET trial?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Interaction between cardiac sympathetic drive and heart rate in heart failure: modulation by adrenergic receptor genotype

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Bucindolol, a nonselective beta 1- and beta 2-adrenergic receptor antagonist, decreases beta-adrenergic receptor density in cultured embryonic chick cardiac myocyte membranes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Carvedilol but not metoprolol reduces beta-adrenergic responsiveness after complete elimination from plasma in vivo

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

A comment on COMET: how to interpret a positive trial?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Specific beta(2)AR blocker ICI 118,551 actively decreases contraction through a G(i)-coupled form of the beta(2)AR in myocytes from failing human heart.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Bisoprolol dose-response relationship in patients with congestive heart failure: a subgroup analysis in the cardiac insufficiency bisoprolol study(CIBIS II).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHI386

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16040619

release_b6gupks2i5faparbhnfpid242q

1 reference

https://api.fatcat.wiki/v0/release/b6gupks2i5faparbhnfpid242q

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16040619

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46616032&oldid=2122294704"